We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Most Claims In Amiodarone Death Case Dismissed With Leave To Refile

Mealey's (March 6, 2019, 11:08 AM EST) -- FRESNO, Calif. — A California federal judge on Feb. 14 dismissed various claims against Pfizer Inc. and Mylan Institutional Inc. in a wrongful death case involving the anti-arrhythmia heart drug amiodarone...
To view the full article, register now.